Literature DB >> 20921513

The Causative Classification of Stroke system: an international reliability and optimization study.

E M Arsava1, E Ballabio, T Benner, J W Cole, M P Delgado-Martinez, M Dichgans, F Fazekas, K L Furie, K Illoh, K Jood, S Kittner, A G Lindgren, J J Majersik, M J Macleod, W J Meurer, J Montaner, A A Olugbodi, A Pasdar, P Redfors, R Schmidt, P Sharma, A B Singhal, A G Sorensen, C Sudlow, V Thijs, B B Worrall, J Rosand, H Ay.   

Abstract

BACKGROUND: Valid and reliable ischemic stroke subtype determination is crucial for well-powered multicenter studies. The Causative Classification of Stroke System (CCS, available at http://ccs.mgh.harvard.edu) is a computerized, evidence-based algorithm that provides both causative and phenotypic stroke subtypes in a rule-based manner. We determined whether CCS demonstrates high interrater reliability in order to be useful for international multicenter studies.
METHODS: Twenty members of the International Stroke Genetics Consortium from 13 centers in 8 countries, who were not involved in the design and development of the CCS, independently assessed the same 50 consecutive patients with acute ischemic stroke through reviews of abstracted case summaries. Agreement among ratings was measured by kappa statistic.
RESULTS: The κ value for causative classification was 0.80 (95% confidence interval [CI] 0.78-0.81) for the 5-subtype, 0.79 (95% CI 0.77-0.80) for the 8-subtype, and 0.70 (95% CI 0.69-0.71) for the 16-subtype CCS. Correction of a software-related factor that generated ambiguity improved agreement: κ = 0.81 (95% CI 0.79-0.82) for the 5-subtype, 0.79 (95% CI 0.77-0.80) for the 8-subtype, and 0.79 (95% CI 0.78-0.80) for the 16-subtype CCS. The κ value for phenotypic classification was 0.79 (95% CI 0.77-0.82) for supra-aortic large artery atherosclerosis, 0.95 (95% CI 0.93-0.98) for cardioembolism, 0.88 (95% CI 0.85-0.91) for small artery occlusion, and 0.79 (0.76-0.82) for other uncommon causes.
CONCLUSIONS: CCS allows classification of stroke subtypes by multiple investigators with high reliability, supporting its potential for improving stroke classification in multicenter studies and ensuring accurate means of communication among different researchers, institutions, and eras.

Entities:  

Mesh:

Year:  2010        PMID: 20921513      PMCID: PMC3013495          DOI: 10.1212/WNL.0b013e3181f612ce

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  18 in total

1.  Effects of interrater reliability of psychopathologic assessment on power and sample size calculations in clinical trials.

Authors:  Matthias J Müller; Armin Szegedi
Journal:  J Clin Psychopharmacol       Date:  2002-06       Impact factor: 3.153

Review 2.  The kappa statistic in reliability studies: use, interpretation, and sample size requirements.

Authors:  Julius Sim; Chris C Wright
Journal:  Phys Ther       Date:  2005-03

3.  Interobserver agreement for the assessment of handicap in stroke patients.

Authors:  J C van Swieten; P J Koudstaal; M C Visser; H J Schouten; J van Gijn
Journal:  Stroke       Date:  1988-05       Impact factor: 7.914

4.  Inter-rater reliability of the Barthel ADL index: how does a researcher compare to a nurse?

Authors:  S H Richards; T J Peters; J Coast; D J Gunnell; M A Darlow; J Pounsford
Journal:  Clin Rehabil       Date:  2000-02       Impact factor: 3.477

5.  Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: the American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists.

Authors:  Harold P Adams; Gregory del Zoppo; Mark J Alberts; Deepak L Bhatt; Lawrence Brass; Anthony Furlan; Robert L Grubb; Randall T Higashida; Edward C Jauch; Chelsea Kidwell; Patrick D Lyden; Lewis B Morgenstern; Adnan I Qureshi; Robert H Rosenwasser; Phillip A Scott; Eelco F M Wijdicks
Journal:  Stroke       Date:  2007-04-12       Impact factor: 7.914

6.  Misclassification and treatment effect on primary outcome measures in clinical trials of severe neurotrauma.

Authors:  Sung C Choi; Guy L Clifton; Anthony Marmarou; Emmy R Miller
Journal:  J Neurotrauma       Date:  2002-01       Impact factor: 5.269

7.  Improving the reliability of stroke subgroup classification using the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) criteria.

Authors:  L B Goldstein; M R Jones; D B Matchar; L J Edwards; J Hoff; V Chilukuri; S B Armstrong; R D Horner
Journal:  Stroke       Date:  2001-05       Impact factor: 7.914

8.  New approach to stroke subtyping: the A-S-C-O (phenotypic) classification of stroke.

Authors:  P Amarenco; J Bogousslavsky; L R Caplan; G A Donnan; M G Hennerici
Journal:  Cerebrovasc Dis       Date:  2009-04-03       Impact factor: 2.762

9.  Interobserver agreement in the trial of org 10172 in acute stroke treatment classification of stroke based on retrospective medical record review.

Authors:  James F Meschia; Kevin M Barrett; Felix Chukwudelunzu; W Mark Brown; L Douglas Case; Brett M Kissela; Robert D Brown; Thomas G Brott; Tammy S Olson; Stephen S Rich; Scott Silliman; Bradford B Worrall
Journal:  J Stroke Cerebrovasc Dis       Date:  2006 Nov-Dec       Impact factor: 2.136

10.  Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.

Authors:  H P Adams; B H Bendixen; L J Kappelle; J Biller; B B Love; D L Gordon; E E Marsh
Journal:  Stroke       Date:  1993-01       Impact factor: 7.914

View more
  39 in total

1.  Stroke Genetics Update: 2011.

Authors:  John W Cole; James F Meschia
Journal:  Curr Cardiovasc Risk Rep       Date:  2011-12-01

2.  Stroke Genetics Network (SiGN) study: design and rationale for a genome-wide association study of ischemic stroke subtypes.

Authors:  James F Meschia; Donna K Arnett; Hakan Ay; Robert D Brown; Oscar R Benavente; John W Cole; Paul I W de Bakker; Martin Dichgans; Kimberly F Doheny; Myriam Fornage; Raji P Grewal; Katrina Gwinn; Christina Jern; Jordi Jimenez Conde; Julie A Johnson; Katarina Jood; Cathy C Laurie; Jin-Moo Lee; Arne Lindgren; Hugh S Markus; Patrick F McArdle; Leslie A McClure; Braxton D Mitchell; Reinhold Schmidt; Kathryn M Rexrode; Stephen S Rich; Jonathan Rosand; Peter M Rothwell; Tatjana Rundek; Ralph L Sacco; Pankaj Sharma; Alan R Shuldiner; Agnieszka Slowik; Sylvia Wassertheil-Smoller; Cathie Sudlow; Vincent N S Thijs; Daniel Woo; Bradford B Worrall; Ona Wu; Steven J Kittner
Journal:  Stroke       Date:  2013-09-10       Impact factor: 7.914

Review 3.  Clinical neurogenetics: stroke.

Authors:  Natalia S Rost
Journal:  Neurol Clin       Date:  2013-07-17       Impact factor: 3.806

4.  Agreement between TOAST and CCS ischemic stroke classification: the NINDS SiGN study.

Authors:  Patrick F McArdle; Steven J Kittner; Hakan Ay; Robert D Brown; James F Meschia; Tatjana Rundek; Sylvia Wassertheil-Smoller; Daniel Woo; Gunnar Andsberg; Alessandro Biffi; David A Brenner; John W Cole; Roderick Corriveau; Paul I W de Bakker; Hossein Delavaran; Martin Dichgans; Raji P Grewal; Katrina Gwinn; Mohammed Huq; Christina Jern; Jordi Jimenez-Conde; Katarina Jood; Robert C Kaplan; Petra Katschnig; Michael Katsnelson; Daniel L Labovitz; Robin Lemmens; Linxin Li; Arne Lindgren; Hugh S Markus; Leema R Peddareddygari; Annie Pedersén; Joanna Pera; Petra Redfors; Jaume Roquer; Jonathan Rosand; Natalia S Rost; Peter M Rothwell; Ralph L Sacco; Pankaj Sharma; Agnieszka Slowik; Cathie Sudlow; Vincent Thijs; Steffen Tiedt; Raffaella Valenti; Bradford B Worrall
Journal:  Neurology       Date:  2014-09-26       Impact factor: 9.910

5.  Large-vessel stenosis in the patients with ischemic stroke in Iran: Prevalence, pattern, and risk factors.

Authors:  Afshin Borhani-Haghighi; Mehrdad Emami; Amin Sadeghi Vasaksi; Abdolhamid Shariat; Mohammad Amin Banihashemi; Alireza Nikseresht; Nahid Ashjazadeh; Sadegh Izadi; Peyman Petramfar; Maryam Poursadegh; Abbas Rahimi Jaberi; Sajjad Emami; Hamid Agheli; Reza Nemati; Ehsan Yaghoubi; Mohammad Hosein Abdi; Mohammad Mohammadi; Peyman Jafari; Salvador Cruz-Flores; Randal Edgell
Journal:  J Vasc Interv Neurol       Date:  2015-02

Review 6.  Current advances in ischemic stroke research and therapies.

Authors:  Derek Barthels; Hiranmoy Das
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-09-15       Impact factor: 5.187

7.  Polygenic Risk for Depression Increases Risk of Ischemic Stroke: From the Stroke Genetics Network Study.

Authors:  Sylvia Wassertheil-Smoller; Qibin Qi; Tushar Dave; Braxton D Mitchell; Rebecca D Jackson; Simin Liu; Ki Park; Joel Salinas; Erin C Dunn; Enrique C Leira; Huichun Xu; Kathleen Ryan; Jordan W Smoller
Journal:  Stroke       Date:  2018-02-08       Impact factor: 7.914

8.  Multiplicity of risk factors in ischemic stroke patients: relations to age, sex, and subtype--a study of 2,505 patients from the lund stroke register.

Authors:  Heléne Starby; Hossein Delavaran; Gunnar Andsberg; Håkan Lövkvist; Bo Norrving; Arne Lindgren
Journal:  Neuroepidemiology       Date:  2014-02-20       Impact factor: 3.282

9.  Prevalence of a Multiple Territory Stroke Pattern After Intravenous Thrombolysis.

Authors:  Muhammad Umer Azeem; Muhammad Nagy; Malgorzata M Miller; Mehdi Ghasemi; Abdul Mikati; Brian Silver; Majaz Moonis; Nils Henninger
Journal:  J Stroke Cerebrovasc Dis       Date:  2020-02-21       Impact factor: 2.136

10.  Oxidative Stress Biomarkers of Brain Damage: Hyperacute Plasma F2-Isoprostane Predicts Infarct Growth in Stroke.

Authors:  Svetlana Lorenzano; Natalia S Rost; Muhib Khan; Hua Li; Fabricio O Lima; Matthew B Maas; Rebecca E Green; Tijy K Thankachan; Allison J Dipietro; Ken Arai; Angel T Som; Loc-Duyen D Pham; Ona Wu; Gordon J Harris; Eng H Lo; Jeffrey B Blumberg; Paul E Milbury; Steven K Feske; Karen L Furie
Journal:  Stroke       Date:  2018-01-25       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.